相关实验视频

Updated: Jan 9, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

利用HLA分歧改善捐赠者选择在哈普洛同一性造血干细胞移植中

Debora Jorge Cordeiro¹, Juliette Villemonteix¹, Alienor Xhaard²

¹Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.

|December 10, 2025

概括

一个新的指标,HLA进化分歧D->R (HED D->R),可以预测平分相同的干细胞移植的结果. 低HED D->R表明生存率较差,有助于对需要移植而没有完全匹配的供体的患者进行供体选择.

科学领域:

免疫遗传学免疫遗传学
移植免疫学移植免疫学
造血干细胞移植造血干细胞移植

背景情况:

对缺乏完全匹配的供体的患者来说,哈普洛同一性造血干细胞移植 (haplo-HSCT) 是至关重要的.
移植后基于循环胺 (PTCy) 的移植与宿主疾病 (GVHD) 预防是哈普罗-HSCT中的标准方法.
HLA进化分歧 (HED) 预测了与HLA匹配的HSCT的结果,但需要适应Haplo-HSCT.

研究的目的:

开发和评估一种新的HED D->R指标,用于预测Haplo-HSCT结果.
评估HED D->R在选择最合适的单双鉴定供体中的有用性.
提供一个工具,以改善患者在Haplo-HSCT的存活率.

主要方法:

对104名接受PTCy哈普洛-HSCT治疗血液恶性瘤的患者进行了回顾性分析.
对接受者 (HED R),捐赠者 (HED D),不匹配的单元型 (HED MM) 和新 HED D->R 度量计算每位位置和每类 HED.
统计分析包括单变量和多变量分析,以确定HED指标对整体存活率 (OS) 的预测值.

主要成果:

低级1HED R与更糟糕的整体存活率 (OS) (HR 2.16) 有关.
没有观察到HED D或HED MM对HSCT结果的显著影响.
在100天以上生存的患者中,低级1HED D->R与劣质的OS显著相关 (HR 2.67).

结论:

接收者类1 HED影响HSCT结果,不论捐赠者匹配.
新的HED D->R指标显示了哈普罗-HSCT结果的预测价值.
HED D->R可以帮助选择最佳的单双相同的捐赠者,潜在地改善患者的存活率.

关键词:

HLA 进化分歧 (HED)血液造血干细胞移植 (HSCT)一个单双相同的捐赠者.免疫皮组 (immunopeptidome) 是一个免疫皮组.

更多相关视频

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...